Condensed Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total		Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain/(Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022			48,941,254
Beginning balance at Dec. 31, 2022	$ 313,342		$ 5	$ 653,707	$ (1,958)	$ (338,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			454,314
Issuance of common stock under benefit plans	3,661			3,661
Common stock issued in a public offering, net of offering expenses (in shares)			9,583,334
Common stock issued in a public offering, net of offering expenses	269,915		$ 1	269,914
Stock-based compensation expense	11,923			11,923
Net unrealized (loss) gain on short-term investments	627				627
Net loss	(37,548)					(37,548)
Ending balance (in shares) at Mar. 31, 2023			58,978,902
Ending balance at Mar. 31, 2023	561,920		$ 6	939,205	(1,331)	(375,960)
Beginning balance (in shares) at Dec. 31, 2022			48,941,254
Beginning balance at Dec. 31, 2022	313,342		$ 5	653,707	(1,958)	(338,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net unrealized (loss) gain on short-term investments	51
Net loss	(120,227)
Ending balance (in shares) at Sep. 30, 2023			59,890,980
Ending balance at Sep. 30, 2023	503,048		$ 6	963,588	(1,907)	(458,639)
Beginning balance (in shares) at Mar. 31, 2023			58,978,902
Beginning balance at Mar. 31, 2023	561,920		$ 6	939,205	(1,331)	(375,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			243,783
Issuance of common stock under benefit plans	334			334
Public offering expenses	(133)			(133)
Stock-based compensation expense	13,046			13,046
Net unrealized (loss) gain on short-term investments	(910)				(910)
Net loss	(41,192)					(41,192)
Ending balance (in shares) at Jun. 30, 2023			59,222,685
Ending balance at Jun. 30, 2023	533,065		$ 6	952,452	(2,241)	(417,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			668,295
Issuance of common stock under benefit plans	774			774
Stock-based compensation expense	10,362			10,362
Net unrealized (loss) gain on short-term investments	334				334
Net loss	(41,487)					(41,487)
Ending balance (in shares) at Sep. 30, 2023			59,890,980
Ending balance at Sep. 30, 2023	$ 503,048		$ 6	963,588	(1,907)	(458,639)
Beginning balance (in shares) at Dec. 31, 2023	59,921,002		59,921,002
Beginning balance at Dec. 31, 2023	$ 473,576	[1]	$ 6	972,973	345	(499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			397,540
Issuance of common stock under benefit plans	1,879			1,879
Stock-based compensation expense	9,666			9,666
Net unrealized (loss) gain on short-term investments	(834)				(834)
Net loss	(46,955)					(46,955)
Ending balance (in shares) at Mar. 31, 2024			60,318,542
Ending balance at Mar. 31, 2024	$ 437,332		$ 6	984,518	(489)	(546,703)
Beginning balance (in shares) at Dec. 31, 2023	59,921,002		59,921,002
Beginning balance at Dec. 31, 2023	$ 473,576	[1]	$ 6	972,973	345	(499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net unrealized (loss) gain on short-term investments	503
Net loss	$ (160,572)
Ending balance (in shares) at Sep. 30, 2024	60,849,503		60,849,503
Ending balance at Sep. 30, 2024	$ 345,822		$ 6	1,005,288	848	(660,320)
Beginning balance (in shares) at Mar. 31, 2024			60,318,542
Beginning balance at Mar. 31, 2024	437,332		$ 6	984,518	(489)	(546,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			106,602
Issuance of common stock under benefit plans	684			684
Stock-based compensation expense	10,644			10,644
Net unrealized (loss) gain on short-term investments	(128)				(128)
Net loss	(55,854)					(55,854)
Ending balance (in shares) at Jun. 30, 2024			60,425,144
Ending balance at Jun. 30, 2024	392,678		$ 6	995,846	(617)	(602,557)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			424,359
Issuance of common stock under benefit plans	543			543
Stock-based compensation expense	8,899			8,899
Net unrealized (loss) gain on short-term investments	1,465				1,465
Net loss	$ (57,763)					(57,763)
Ending balance (in shares) at Sep. 30, 2024	60,849,503		60,849,503
Ending balance at Sep. 30, 2024	$ 345,822		$ 6	$ 1,005,288	$ 848	$ (660,320)

[1] The condensed balance sheet as of December 31, 2023 has been derived from the audited financial statements as of that date.